Randomized comparison of absorb bioresorbable vascular scaffold and mirage microfiber sirolimus-eluting scaffold using multimodality imaging
JACC cardiovasc. interv
; 10(11): 1115-1130, 2017. ilus, graf, tab
Article
em En
| SES-SP, SESSP-IDPCPROD, SES-SP
| ID: biblio-1064044
Biblioteca responsável:
BR79.1
Localização: BR79.1
ABSTRACT
ObjectivesThe primary objective of this study was to evaluate the safety and effectiveness of the Mirage (Manli Cardiology, Singapore) bioresorbable microfiber sirolimus-eluting scaffold compared with the Absorb (Abbott Vascular, Santa Clara, California) bioresorbable vascular scaffold in the treatment of stenotic target lesions located in native coronary arteries, ranging from ≥2.25 to ≤4.0 mm in diameter. Secondary objectives were to establish the medium-term safety, effectiveness, and performance of the Mirage device.BackgroundThe current generation of bioresorbable scaffolds has several limitations, such as thick square struts with large footprints that preclude their deep embedment into the vessel wall, resulting in protrusion into the lumen with microdisturbance of flow. The Mirage sirolimus-eluting bioresorbable microfiber scaffold is designed to address these concerns....
Texto completo:
1
Coleções:
06-national
/
BR
Base de dados:
SES-SP
/
SESSP-IDPCPROD
Assunto principal:
Doenças Vasculares
/
Procedimentos Cirúrgicos Vasculares
/
Sirolimo
Tipo de estudo:
Clinical_trials
Idioma:
En
Revista:
JACC cardiovasc. interv
Ano de publicação:
2017
Tipo de documento:
Article